Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Not sure I wanted to bring this topic up (again.)

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Jun 13, 2024 12:21pm

147 Views

Post# 36087323

RE:RE:RE:RE:RE:Not sure I wanted to bring this topic up (again.)

Agree Legit, a little over a year ago someone very experienced and successful in the field of Oncology told me he estimated TLT was worth in the area of $3 billion or roughly $10 p/s. Further, if they could make any kind of progress in GBM etc. it would greatly increase that value, and these people are talking about $1.50 or $2 p/s???

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles